Page last updated: 2024-08-24

imiquimod and sirolimus

imiquimod has been researched along with sirolimus in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Babel, N; Bold, G; Eibl, N; Hammer, MH; Reinke, P; Rosenberger, C; Sefrin, A; Ulrich, C1
De Meyer, GR; De Meyer, I; Martinet, W; Schrijvers, DM; Timmermans, JP; Verheye, S1
Bürger, C; Diehl, S; Han, YY; Kaufmann, R; Lang, V; Ringel, C; Shirsath, N; Weigert, A; Wolf, P1
Lipner, SR1
Gao, M; Si, X1
Blake, T; Lobo, Y; Wheller, L1
Chung, BY; Kang, SY; Kim, HO; Kim, HR; Kim, JC; Park, CW1
Jiang, X; Li, X; Liu, L; Yang, L; Zhao, Q1

Reviews

4 review(s) available for imiquimod and sirolimus

ArticleYear
Drug-induced macrophage autophagy in atherosclerosis: for better or worse?
    Basic research in cardiology, 2013, Volume: 108, Issue:1

    Topics: Aminoquinolines; Animals; Autophagy; Cytokines; Everolimus; Humans; Imiquimod; Macrophages; Mice; Plaque, Atherosclerotic; Sirolimus; Toll-Like Receptor 7; TOR Serine-Threonine Kinases

2013
Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:6

    Topics: Administration, Cutaneous; Aminoquinolines; Clinical Trials as Topic; Combined Modality Therapy; Dermatologic Agents; Humans; Imiquimod; Lasers, Dye; Port-Wine Stain; Randomized Controlled Trials as Topic; Sirolimus; Timolol; Treatment Outcome

2018
Management of multiple trichoepithelioma: A review of pharmacological therapies.
    The Australasian journal of dermatology, 2021, Volume: 62, Issue:2

    Topics: Adalimumab; Administration, Topical; Anilides; Antineoplastic Agents; Aspirin; Humans; Imiquimod; Lasers, Gas; Neoplasms, Adnexal and Skin Appendage; Pyridines; Sirolimus; Skin Neoplasms; Tretinoin

2021
Pathogenesis of Port-Wine Stains: Directions for Future Therapies.
    International journal of molecular sciences, 2022, Oct-12, Volume: 23, Issue:20

    Topics: Angiopoietin-2; Axitinib; Ephrin-B2; Humans; Imiquimod; Phosphatidylinositol 3-Kinases; Photosensitizing Agents; Port-Wine Stain; Proto-Oncogene Proteins c-akt; Receptor, EphA1; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2

2022

Other Studies

4 other study(ies) available for imiquimod and sirolimus

ArticleYear
Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:1

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Graft Rejection; Herpesvirus 8, Human; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Sarcoma, Kaposi; Sirolimus

2008
Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice.
    Acta dermato-venereologica, 2017, Oct-02, Volume: 97, Issue:9

    Topics: Administration, Topical; Aminoquinolines; Animals; Caspase 14; Dendritic Cells; Disease Models, Animal; Imiquimod; Immunosuppressive Agents; Keratin-10; Keratin-14; Ki-67 Antigen; Langerhans Cells; Lymph Nodes; Macrophages; Membrane Proteins; Mice, Inbred BALB C; Neovascularization, Physiologic; Protein Precursors; Psoriasis; Sirolimus; Skin; TOR Serine-Threonine Kinases

2017
Rapamycin ameliorates psoriasis by regulating the expression and methylation levels of tropomyosin via ERK1/2 and mTOR pathways in vitro and in vivo.
    Experimental dermatology, 2018, Volume: 27, Issue:10

    Topics: Animals; Cell Proliferation; Cytoskeleton; Down-Regulation; Female; Gene Expression; HEK293 Cells; Humans; Imiquimod; Immunosuppressive Agents; Keratinocytes; Male; MAP Kinase Signaling System; Methylation; Mice; Psoriasis; S Phase Cell Cycle Checkpoints; Sirolimus; TOR Serine-Threonine Kinases; Tropomyosin

2018
Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy.
    International journal of molecular sciences, 2021, Apr-12, Volume: 22, Issue:8

    Topics: Animals; Autophagy; Cell Differentiation; Cells, Cultured; Cytochrome P-450 CYP1A1; Dermatitis; Gene Expression Regulation; Humans; Imiquimod; Inflammation; Keratinocytes; Mice; NADPH Oxidase 4; NF-E2-Related Factor 2; Polychlorinated Dibenzodioxins; Psoriasis; Receptors, Aryl Hydrocarbon; Sirolimus

2021